Key facts
- This page summarizes Jane Wright-Mitchell's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Aug 2021, 18:02.
Jane Wright-Mitchell - 16 Aug 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Reporting relationship
- General Counsel
- Issuer ticker
- PCVX
- Reported as of
- 16 Aug 2021
- Net transaction value
- -$59,925
- SEC form
- 4
- Accepted by SEC
- 18 Aug 2021, 18:02:03 UTC
- Prior SEC filing
- 16 Aug 2021
- Next SEC filing
- 25 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ron A. Metzger, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jane Wright-Mitchell filed Form 4 for Vaxcyte, Inc. (PCVX) on 18 Aug 2021.
Change
- Previous filing in this sequence was filed on 16 Aug 2021.
- Current net transaction value: -$59,925.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCVX
transaction
Common Stock
Options Exercise
- Transaction value
- $5,075
- Shares
- +2,500
- Change %
- +80%
- Price
- $2.03*
- Shares after
- 5,625
- Date
- 16 Aug 2021
- Ownership
- Direct
PCVX
transaction
Common Stock
Sale
- Transaction value
- $65,000
- Shares
- -2,500
- Change %
- -44%
- Price
- $26.00
- Shares after
- 3,125
- Date
- 16 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCVX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,500
- Change %
- -1.3%
- Price
- $0.000000
- Shares after
- 187,468
- Date
- 16 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500
- Exercise price
- $2.03
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Footnote F2
1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.